ASCO 2018: highlights of urothelial cancer and prostate cancer

Prostate cancer and urothelial carcinoma are the two most common urological cancers. The aim of this short review is to highlight abstracts from this year’s ASCO Annual Meeting. The phase III SPCG-13 trial showed no difference in biochemical disease-free survival by the addition of docetaxel after p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichler, Renate, Horninger, Wolfgang, Heidegger, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2018
Materias:
Short Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280775/
https://www.ncbi.nlm.nih.gov/pubmed/30595755
http://dx.doi.org/10.1007/s12254-018-0422-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280775/
https://www.ncbi.nlm.nih.gov/pubmed/30595755
http://dx.doi.org/10.1007/s12254-018-0422-0

Ejemplares similares